Related Experiment Video
Updated: Jan 20, 2026

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
Vascular Detransformation for Cancer Therapy.
1Departments of Radiation Oncology and Neurosurgery, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Immunology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Cancer vascularity may be driven by endothelial transformation, not just angiogenesis. Targeting this "vascular detransformation" could offer a new therapeutic strategy against cancer, overcoming current treatment limitations.
Area of Science:
- Oncology
- Cancer Biology
- Vascular Biology
Background:
- Angiogenesis is a critical hallmark of cancer.
- Current anti-vascular therapies targeting angiogenic factors show limited success in most cancers.
- Alternative mechanisms driving tumor vascularity require investigation.
Purpose of the Study:
- To propose endothelial transformation as a key driver of tumor vascularity.
- To explore endothelial transformation's role in cancer progression and immune suppression.
- To investigate endothelial transformation's contribution to therapeutic resistance.
Main Methods:
- Conceptual review of existing literature on angiogenesis and endothelial cell biology.
- Hypothesis generation based on observed limitations of current anti-angiogenic therapies.
- Proposed framework for understanding vascular abnormalities in cancer.
Main Results:
- Endothelial transformation is hypothesized to drive excessive and abnormal tumor vascularity.
- This transformation contributes to cancer progression and immune evasion.
- It also underlies resistance to existing cancer therapies.
Conclusions:
- Vascular detransformation, reversing endothelial transformation, presents a novel therapeutic strategy.
- This approach may overcome limitations of current anti-angiogenic treatments.
- Targeting vascular detransformation holds promise for improving cancer treatment outcomes.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Seedless Vascular Plants
Gene Therapy
Group Therapy
Vascular Spasm

